(Medical Xpress) -- New data from the University of Rochester Medical Center confirms that an easier, two-drug chemotherapy regimen given to bladder cancer patients prior to surgery shrinks locally advanced tumors and completely ...
Aug 19, 2011
0
0
In a new paper accepted for publication in the Journal of the American Society of Nephrology, researchers at Yale School of Medicine share findings that indicate that, for the first time, there is a potential renal targeted ...
Dec 7, 2021
0
6
An international trial has found that a medicine commonly used to treat poisoning is effective in reducing deafness in children receiving chemotherapy for cancer.
Jun 21, 2018
0
27
Modern medicine offers "peel and stick" solutions like nicotine or contraceptive patches that you can put right on your skin without needing to visit a doctor for an injection or procedure. Now, researchers have found that ...
Mar 30, 2022
0
7
(Medical Xpress)—Researchers at the University of Georgia have developed a new prodrug that promises to reduce many of the negative side effects caused by cisplatin, a commonly prescribed chemotherapy treatment.
Jan 10, 2014
0
0
Investigators at The Saban Research Institute of Children's Hospital Los Angeles have found that the gene PID1 enhances killing of medulloblastoma and glioblastoma cells. Medulloblastoma is the most commonly occurring malignant ...
Apr 11, 2017
0
5
Researchers at the University Hospital Bonn (UKB) have now been able to elucidate a mechanism underlying cisplatin resistance in testicular cancer. Using CRISPR gene scissors, they identified the NAE1 gene as its driver. ...
Apr 11, 2023
0
35
Lung cancer patients could receive safer and more efficient treatment through a system being developed by researchers at the University of Strathclyde in Glasgow.
Oct 11, 2011
0
1
A select subgroup of advanced head and neck cancer patients treated with radiation therapy plus the chemotherapy drug cisplatin had more positive outcomes than patients treated with radiation therapy alone and continued to ...
Jan 26, 2012
0
0
Charity Action on Hearing Loss is supporting the biotechnology firm Otomagnetics, which today announces an important breakthrough towards preventing hearing loss caused by a widely used chemotherapy drug.
Sep 12, 2017
0
8
